Should we treat concussion pharmacologically? The need for evidence based pharmacological treatment for the concussed athlete.
McCrory
P
P
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D016718:Arachidonic Acid / Q000037:antagonists & inhibitors; D001924:Brain Concussion / Q000188:drug therapy* / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D016166:Free Radical Scavengers / Q000627:therapeutic use; D006801:Humans; D006931:Hyperbaric Oxygenation; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009292:Narcotic Antagonists; D009414:Nerve Growth Factors / Q000627:therapeutic use; D013973:Thyrotropin-Releasing Hormone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000975:Antioxidants; D002121:Calcium Channel Blockers; D018691:Excitatory Amino Acid Antagonists; D016166:Free Radical Scavengers; D008996:Monoamine Oxidase Inhibitors; D009292:Narcotic Antagonists; D009414:Nerve Growth Factors; D016718:Arachidonic Acid; D013973:Thyrotropin-Releasing Hormone